Attock Refinery Limited (ARL) has announced the approval of the sale of a 70% stake in its wholly owned subsidiary, Attock Hospital (Private) Limited, for a consideration of PKR 305 million. The decision was taken by the company’s Board of Directors during a meeting held on June 19, 2026.
According to the disclosure submitted to the Pakistan Stock Exchange (PSX), the Board approved an offer submitted by Mr. Suhaib A. Malik for the acquisition of 70% of the issued and paid-up share capital of Attock Hospital (Private) Limited. The transaction forms part of ARL’s strategic corporate decisions and is expected to proceed upon completion of all necessary legal, regulatory, and corporate formalities.
The refinery stated that the proposed sale remains subject to the execution of definitive transaction documents and the receipt of all requisite approvals and consents from relevant authorities. The company emphasized that it will continue to keep the stock exchange informed of any material developments related to the transaction.
Attock Hospital (Private) Limited is a wholly owned subsidiary of Attock Refinery Limited. The divestment of a majority stake may allow ARL to streamline its portfolio and focus more closely on its core refining and energy operations, while bringing in a new majority shareholder to manage and develop the healthcare business.
Investors will be watching for further details regarding the completion timeline, regulatory approvals, and the future ownership structure of Attock Hospital as the transaction progresses.
